Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

5.8%

6 terminated out of 104 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

6%

6 trials in Phase 3/4

Results Transparency

17%

5 of 30 completed with results

Key Signals

5 with results83% success

Data Visualizations

Phase Distribution

88Total
Not Applicable (30)
Early P 1 (2)
P 1 (24)
P 2 (26)
P 3 (4)
P 4 (2)

Trial Status

Completed30
Unknown30
Recruiting22
Active Not Recruiting6
Terminated6
Withdrawn5

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 30 completed trials

Clinical Trials (104)

Showing 20 of 20 trials
NCT07730619Active Not Recruiting

To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing Relapse

NCT06347068Phase 1Recruiting

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

NCT05927558Completed

Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study

NCT06096038Phase 1Recruiting

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

NCT06618755Not ApplicableRecruiting

Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool

NCT05911321Phase 2Active Not Recruiting

Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

NCT06158139Phase 1Recruiting

Autologous CAR-T Cells Targeting B7-H3 in PDAC

NCT04176718Phase 2Active Not Recruiting

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

NCT07622277Not ApplicableRecruiting

Comparative 3-dimensional Superimposition Analysis of Dentition in Horizontal and Vertical Grower During the Retention Phase -A Prospective Clinical Trial''

NCT07611838Recruiting

Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction

NCT07604909Phase 2Recruiting

A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy

NCT07570407Not Yet Recruiting

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

NCT04864626Active Not Recruiting

Study of the Impact on the Evolution of the Disease in the Medium Term of the Implementation of a System of Extended Follow-up by Telephone Interview of Patients With an Eating Disorder Organized by the Nurses of the Eating Disorder Referral Center

NCT07552623Not ApplicableCompleted

Adapted RPM-08 for Substance Use Disorder in Pakistan

NCT05861947Phase 1TerminatedPrimary

A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

NCT07448376Not Yet Recruiting

EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

NCT06919939Phase 2Recruiting

Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma

NCT03029338Phase 1Completed

CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma

NCT04139434Phase 1Completed

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

NCT07287228Phase 1Not Yet Recruiting

The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia

Scroll to load more

Research Network

Activity Timeline